IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Alamar Biosciences, Inc.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Change from offer price to today
Real-time price; headline % change is vs first trade (listing price)
USD · NASDAQ:NASDAQ:ALMR
Key valuation ratios and metrics
Balance sheet strength and liquidity
Street consensus and price targets
Volatility versus the market
Upcoming and recent earnings
Historical financial performance
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | $22.99 | $24.88 | $22.75 | $23.01 | $23.01 | +0.02 | 222,300 |
| 2026-05-12 | $23.92 | $24.97 | $22.76 | $22.97 | $22.97 | -0.95 | 158,700 |
| 2026-05-11 | $23.90 | $25.00 | $23.59 | $23.88 | $23.88 | -0.02 | 139,100 |
| 2026-05-08 | $23.12 | $25.21 | $23.12 | $23.96 | $23.96 | +0.84 | 304,600 |
| 2026-05-07 | $23.85 | $24.12 | $22.75 | $23.66 | $23.66 | -0.19 | 270,100 |
| 2026-05-06 | $24.10 | $24.83 | $23.63 | $23.84 | $23.84 | -0.26 | 289,600 |
| 2026-05-05 | $23.67 | $24.42 | $23.13 | $23.90 | $23.90 | +0.23 | 122,700 |
| 2026-05-04 | $25.66 | $26.57 | $23.58 | $23.76 | $23.76 | -1.90 | 181,900 |
| 2026-05-01 | $25.12 | $26.87 | $25.04 | $25.81 | $25.81 | +0.69 | 380,900 |
| 2026-04-30 | $24.56 | $25.71 | $24.50 | $25.04 | $25.04 | +0.48 | 226,600 |
| 2026-04-29 | $26.37 | $26.68 | $23.71 | $24.48 | $24.48 | -1.89 | 222,000 |
| 2026-04-28 | $26.69 | $27.20 | $25.59 | $26.11 | $26.11 | -0.58 | 227,400 |
| 2026-04-27 | $24.67 | $27.00 | $24.28 | $26.69 | $26.69 | +2.02 | 429,500 |
| 2026-04-24 | $24.45 | $24.98 | $24.28 | $24.84 | $24.84 | +0.39 | 707,700 |
| 2026-04-23 | $24.55 | $24.55 | $23.05 | $24.27 | $24.27 | -0.28 | 187,000 |
| 2026-04-22 | $23.24 | $25.03 | $22.75 | $24.27 | $24.27 | +1.03 | 342,400 |
| 2026-04-21 | $21.75 | $23.68 | $21.75 | $23.23 | $23.23 | +1.48 | 457,300 |
| 2026-04-20 | $22.34 | $24.50 | $21.80 | $22.00 | $22.00 | -0.34 | 1,069,500 |
| 2026-04-17 | $22.60 | $24.50 | $21.50 | $22.00 | $22.00 | -0.60 | 4,895,500 |
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| 10-Q | May 8, 2026 | Quarterly Report |
| 8-K | May 8, 2026 | Current Report |
| SCHEDULE 13D | Apr 23, 2026 | Filing |
| SCHEDULE 13D | Apr 23, 2026 | Filing |
| EFFECT | Apr 20, 2026 | Notice of Effectiveness |
| S-8 | Apr 20, 2026 | Securities to be offered to employees in employee benefit plans |
| 8-K | Apr 20, 2026 | Current Report |
| POS AM | Apr 20, 2026 | Post-Effective amendments for registration statement |
| 424B4 | Apr 17, 2026 | Prospectus |
| EFFECT | Apr 16, 2026 | Notice of Effectiveness |
Contact and headquarters details
Key executives and officers
Yuling Luo, Ph.D.
Founder, Chief Executive Officer and Chairman
Timothy “Tod” White
President
Justin McAnear
Chief Financial Officer
Shiping “Steve” Chen, Ph.D.
Founder, Chief Operating Officer and Director
Rebecca Chambers
Director
Nicholas Naclerio, Ph.D.
Director
Ian W. Ratcliffe
Director
Frank R. Witney, Ph.D.
Director

USD · NASDAQ:ALMR
Issue Size
$191.25M
Price Range
$17.00
Shares
69.31M o/s · 11.25M offered
Listing Price
$22.60
Listing date
Apr 17, 2026
Sector
Healthcare